Cita APA (7a ed.)

S, W., & X, L. (2020). CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press.

Cita Chicago Style (17a ed.)

S, Wang, y Liu X. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press, 2020.

Cita MLA (8a ed.)

S, Wang, y Liu X. CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]. Dove Medical Press, 2020.